Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Opioid Settlements topic

No spam. Unsubscribe anytime.

Del City Council approves opioid-settlement participation and interlocal agreement for Rose Lane revitalization grant

5826720 · September 25, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

At a Sept. 23 special meeting the Del City City Council approved two council actions: entering an interlocal agreement with ACOG for a SIRI grant for the Rose Lane revitalization project, and a council resolution authorizing participation in national opioid settlements; both measures passed unanimously.

The Del City City Council on Sept. 23 moved quickly through a short special meeting to approve a consent docket, ratify an interlocal agreement tied to a state/regional grant, and authorize the city’s participation in national opioid settlements discussed in an executive session.

The council voted unanimously to approve budget amendments listed on the consent docket and then approved entering into an interlocal agreement with the Association of Central Oklahoma Governments (ACOG) to accept a 2025–26 SIRI program award to Del City for the Revitalizing Rose Lane project. “Congratulations on winning this grant. Good job — tell your staff,” Chair/Mayor Eason said after the motion.

The council then recessed into executive session to discuss confidential matters related to pending investigations, claims and actions concerning opioid litigation. The executive-session notice cited Oklahoma statutes authorizing confidential deliberations where disclosure could impair litigation and specified pending settlement participation with Purdue Pharma LP and claims involving several pharmaceutical manufacturers.

When the council returned to open session, trustees moved to approve a resolution authorizing the city to participate in settlement agreements with Purdue Pharma LP, members of the Sackler family, and multiple manufacturers named in the executive-session notice. The motion, later amended to explicitly authorize the resolution, passed unanimously; Mayor Eason was authorized to execute the city’s participation form.

The executive-session agenda item cited Oklahoma Statutes Title 25, Section 307(b)(4), which permits limited confidentiality for pending investigations or litigation when disclosure would seriously impair the public interest, and the clerk recorded a motion and vote approving the city’s participation in the settlements.

Votes at a glance - Consent docket: budget amendments for FY 2025–26 and FY 2024–25 (items A & B) — approved unanimously. - ACOG interlocal agreement (SIRI 2025–26, Revitalizing Rose Lane): approved unanimously; mayor authorized to endorse agreement. - City resolution to participate in opioid settlements (Resolution 092525A): approved unanimously; mayor authorized to sign participation forms; motion included authorization to execute subdivision participation documents.

What the council did not do The council conducted the detailed opioid discussion in executive session and did not disclose the terms of the proposed settlements during open session; the action at open session was limited to authorizing participation and execution of settlement participation forms as advised by city counsel.

Ending note Council members recorded unanimous votes on each item. The council’s public materials identify the Rose Lane project as the SIRI grant award recipient; copies of the executed interlocal agreement and the city’s participation documents in the opioid settlements will be part of the city’s public records once finalized and filed, subject to any confidentiality limits counsel identified for ongoing litigation purposes.